info icon

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

C3_ENDOCRINE_NAS_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C75
  • Hospital discharge: ICD-9 194[1-9]
  • Hospital discharge: ICD-8 194[1-9]
  • Cause of death: ICD-10 C75
  • Cause of death: ICD-9 194[1-9]
  • Cause of death: ICD-8 194[1-9]
  • Cancer registry: Topography ICD-O-3 C75
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

161

4. Check minimum number of events

None

161

5. Include endpoints

None

161

6. Filter based on genotype QC (FinnGen only)

161

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

List of similar endpoints to Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 161 94 67
Unadjusted period prevalence (%) 0.03 0.03 0.03
Median age at first event (years) 55.89 49.55 64.79

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
40
32
16.30
42.55
1.6
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
89
337
4.67
21.21
11.1
2.7
ph
7.4
7.4
0.55
31
46
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
19
12.56
20.19
3.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
20
10.64
16.44
2.8
1.2
nmol/l
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
111
4.61
14.46
3.6
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
101
519
3.54
13.69
15.1
5.6
mmol/l
1.2
1.2
0.91
96
466
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
107
585
3.47
12.82
15.2
5.7
mmol/l
1.2
1.2
0.68
76
504
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
34
89
4.58
12.40
8.5
3.4
ng/l
117.2
79.7
0.79
28
77
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
15
10.13
11.83
1.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
13
9.01
8.56
3.6
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
16
8.02
8.53
3.0
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
94
3.40
7.07
3.5
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
20
6.40
7.01
2.9
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
62
330
2.43
6.58
3.0
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
99
1273
0.42
6.22
4.3
4.4
mmol/l
1.4
1.5
1.07
91
1175
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
104
1307
0.42
5.98
4.7
4.9
mmol/l
2.6
2.7
0.31
94
1211
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
94
1224
0.44
5.79
3.8
4.0
mmol/l
1.4
1.2
1.60
85
1118
(40768804) Tissue Pathology biopsy report
69
407
2.22
5.59
2.1
1.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
20
63
3.48
5.53
8.2
10.1
%
96.0
93.1
2.57
20
63
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
102
1282
0.44
5.51
4.3
4.4
mmol/l
4.5
4.6
0.33
94
1192
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
5
16.72
5.47
2.1
1.2
nmol/l
56.8
62.2
—
8
5
(3002256) Pathology report gross observation
25
92
3.03
5.40
1.3
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
73
451
2.13
5.17
11.4
9.9
inr
1.3
1.3
0.03
31
127
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
19
61
3.40
5.10
10.3
5.6
mmol/l
24.5
25.3
0.46
19
61
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
5
14.54
4.62
2.6
1.2
ug/l
21.0
21.8
—
7
5
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
88
601
2.02
4.60
10.3
3.6
umol/l
15.4
11.3
0.32
81
555
(3026782) Osmolality of Urine
44
232
2.23
4.56
2.5
2.5
mosm/kgh2o
500.5
541.1
0.68
39
181
(3000991) Gas panel - Venous blood
23
89
2.85
4.54
9.4
8.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
75
491
1.99
4.36
6.4
3.7
g/l
34.8
35.8
0.67
69
457
(36304419) Bacteria [Presence] in Urine
54
326
1.99
3.87
3.1
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
521
1.87
3.69
5.5
3.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
15
51
3.14
3.68
1.7
1.3
iu/l
21.8
20.7
—
10
43
(3002582) Erythrocytes [#/volume] in Urine
58
367
1.91
3.58
3.5
2.8
e6/l
83.5
251.6
0.40
49
261
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
6
10.32
3.52
2.8
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
54
337
1.91
3.46
3.2
2.6
e6/l
0.4
0.4
0.18
47
229
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
27
3.88
3.41
1.8
1.6
u/ml
0.4
0.4
—
5
13
(40760888) Immunoglobulin light chains.free panel - Serum
8
14
5.95
3.38
2.5
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
14
50
2.97
3.17
9.0
11.1
mmol/l
24.1
25.1
0.82
14
44
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
16
5.20
3.09
3.0
4.3
%
63.9
62.3
—
8
16
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
16
5.20
3.09
2.9
3.2
e9/l
5.0
5.5
—
8
16
(42870588) Differential panel, method unspecified - Blood
58
383
1.80
3.06
6.7
4.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
21
4.47
3.04
4.1
1.7
kpa
4.7
4.8
—
9
21
(3027315) Oxygen [Partial pressure] in Blood
9
21
4.47
3.04
4.1
1.7
kpa
8.8
8.1
—
9
21
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
5
10.26
3.00
10.0
4.0
ug/l
4.0
1.6
—
5
5
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
63
429
1.77
2.98
3.5
2.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
30
161
2.06
2.91
2.0
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
63
434
1.74
2.84
4.3
3.2
e6/l
154.1
104.6
0.31
51
281
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
41
248
1.88
2.84
2.8
2.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
9
23
4.08
2.82
1.3
1.8
%
88.3
92.0
—
9
23
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
74
535
1.71
2.80
3.5
2.2
nmol/l
76.2
77.0
0.10
67
471
(3016018) Differential panel - Cerebral spinal fluid
6
10
6.18
2.72
1.8
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
24
3.91
2.71
1.8
1.3
—
—
—
0
0
(3036489) Thrombin time
10
33
3.16
2.57
1.5
1.6
s
22.1
19.9
—
10
28
(3003396) Base excess in Arterial blood by calculation
24
124
2.10
2.57
6.9
11.3
mmol/l
0.3
1.5
0.67
19
100
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
7
7.32
2.56
1.2
2.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
20
96
2.24
2.56
12.3
6.9
mmol/l
1.1
1.4
1.34
20
89
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
8
21
3.95
2.50
1.5
2.3
g/l
3.6
4.1
—
8
21
(40758558) Short blood count panel - Blood
45
291
1.76
2.49
12.9
4.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
27
148
1.99
2.47
1.4
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
12
5.15
2.42
6.8
1.4
u/ml
3.1
310.8
—
6
12
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
114
946
1.70
2.41
14.3
4.8
u/l
88.8
75.8
1.35
108
861
(3010838) Calcium [Moles/time] in 24 hour Urine
5
8
6.40
2.39
1.4
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
74
552
1.63
2.38
16.1
7.2
e9/l
0.0
0.0
0.61
63
429
(3004588) Protein electrophoresis panel - Serum or Plasma
16
72
2.36
2.36
2.7
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
45
295
1.73
2.36
6.7
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
48
321
1.71
2.35
1.6
1.4
—
—
—
0
0
(3012544) pH of Venous blood
23
122
2.03
2.30
9.3
3.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
13
4.75
2.29
1.7
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
110
1260
0.60
2.26
5.2
4.5
mmol/l
6.0
6.0
0.15
98
1148
(3010813) Leukocytes [#/volume] in Blood
133
1449
0.53
2.24
38.6
17.1
e9/l
7.0
6.7
1.30
128
1396
(3026361) Erythrocytes [#/volume] in Blood
133
1449
0.53
2.24
38.6
17.1
e12/l
4.4
4.5
0.88
128
1395
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
9
5.69
2.23
1.8
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
86
678
1.58
2.13
17.8
5.9
e9/l
4.3
4.3
0.03
77
588
(3007461) Platelets [#/volume] in Blood
133
1446
0.54
2.12
38.6
17.1
e9/l
250.2
249.9
0.01
128
1398
(21494890) Protein electrophoresis panel - 24 hour Urine
5
10
5.12
2.08
2.6
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
20
3.61
2.08
3.1
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
57
2.39
2.03
14.9
3.8
mmol/l
23.3
24.7
0.76
13
51
(3037756) Immunofixation for Serum or Plasma
6
16
3.85
1.95
1.2
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
40
269
1.65
1.89
5.2
4.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
27
165
1.76
1.79
2.3
2.6
ug/g
145.4
92.3
0.29
22
121
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
13
3.93
1.73
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
13
3.93
1.73
1.0
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
16
83
2.03
1.71
3.4
4.2
%
1.3
0.8
—
8
16
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
19
3.24
1.67
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
15
79
1.99
1.55
3.5
4.4
%
0.9
0.1
—
7
14
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
15
3.40
1.53
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
15
3.40
1.53
1.0
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
87
1.93
1.52
1.8
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
37
2.52
1.50
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
99
1126
0.69
1.47
35.6
15.5
g/l
331.6
332.6
0.37
99
1121
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
27
176
1.64
1.43
1.8
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
44
323
1.50
1.41
5.0
3.8
estimate
0.0
0.0
0.00
22
89
(3023520) Reticulocytes [#/volume] in Blood
18
105
1.80
1.40
2.5
2.2
e9/l
72.0
65.9
—
10
84
(3025159) Blasts/100 leukocytes in Blood
14
75
1.95
1.39
3.7
4.4
%
0.2
0.0
—
6
13
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
114
1004
1.46
1.38
7.8
3.8
pmol/l
15.5
14.7
2.35
109
905
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
41
0.00
1.33
0.0
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
73
601
1.39
1.25
7.5
4.7
e9/l
0.6
0.6
0.07
64
516
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
79
1.85
1.21
1.1
1.2
iu/ml
58.4
118.7
—
8
30
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
36
262
1.48
1.20
2.1
1.8
pmol/l
537.7
26635951.8
0.50
28
214
(3006315) Basophils [#/volume] in Blood
73
605
1.38
1.19
7.5
4.7
e9/l
0.0
0.0
1.31
64
522
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
129
1381
0.67
1.16
15.7
8.3
u/l
27.0
24.5
1.00
120
1318
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
30
2.39
1.14
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
125
0.46
1.10
1.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
74
621
1.35
1.09
7.9
4.8
e9/l
1.7
1.9
1.10
66
544
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5
108
0.45
1.05
2.8
2.3
—
10.4
—
0
5
(3024928) Oxygen saturation in Venous blood
5
22
2.31
1.04
24.0
4.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
74
625
1.34
1.03
8.8
5.1
e9/l
0.1
0.2
2.25
66
549
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
261
1.44
1.03
1.5
1.7
mg/l
1.8
1.1
0.47
20
203
(3025941) Bacteria identified in Stool by Culture
12
69
1.80
0.99
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
23
2.21
0.98
1.2
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
176
1.50
0.98
2.1
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
127
1.56
0.93
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
119
1.58
0.93
1.8
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
119
1.58
0.93
1.9
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
97
861
1.32
0.93
3.7
3.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
109
1186
0.75
0.90
6.4
6.2
mmol/mol
41.1
40.5
0.29
98
1108
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
72
1.72
0.88
1.1
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
128
1358
0.72
0.86
23.0
10.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
45
1.82
0.85
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
46
1.78
0.84
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
243
0.66
0.82
1.4
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
47
1.74
0.82
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
8
47
1.74
0.82
6.3
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
7
123
0.55
0.82
2.3
2.5
ug/l
4.8
6.2
—
7
111
(3019832) Treponema pallidum Ab [Presence] in Serum
7
125
0.54
0.81
1.7
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
48
1.70
0.80
1.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
26
0.00
0.79
0.0
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
27
203
1.40
0.77
2.9
2.3
e6/l
134.8
1.3
0.47
12
104
(3026008) Bacteria identified in Urine by Culture
45
368
1.31
0.76
3.1
3.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
73
823
0.79
0.72
3.3
3.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
26
1.95
0.71
1.4
3.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
58
1.58
0.71
14.1
2.5
%
1.3
1.3
—
9
58
(3035350) Ketones [Presence] in Urine by Test strip
71
621
1.26
0.70
4.5
3.5
estimate
0.0
0.0
0.00
23
95
(3024354) Oxygen [Partial pressure] in Venous blood
14
96
1.50
0.64
10.8
3.0
kpa
6.6
4.1
1.15
14
90
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
25
195
1.33
0.59
2.8
2.5
e6/l
0.8
4.2
—
8
96
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
35
1.74
0.58
4.3
2.0
kpa
9.3
9.0
—
6
30
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
54
1.51
0.58
12.5
18.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
215
0.72
0.57
1.5
1.3
u/ml
2.4
12.5
—
5
87
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
37
1.65
0.56
3.7
1.1
g/l
42.7
38.5
—
6
31
(3019309) Folate [Moles/volume] in Red Blood Cells
31
252
1.29
0.55
2.4
1.7
nmol/l
1405.0
1107.9
0.60
20
195
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
6
39
1.56
0.53
1.8
1.4
ug/l
5.7
2.1
—
6
33
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
100
0.58
0.53
1.7
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
64
1.43
0.52
1.7
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
19
145
1.35
0.51
1.5
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
65
579
1.21
0.51
4.2
2.6
ug/l
173.0
107.5
0.59
58
535
(3021601) Nitrite [Presence] in Urine by Test strip
70
628
1.20
0.51
5.7
4.9
estimate
0.0
0.0
0.00
22
95
(3009261) Glucose [Presence] in Urine by Test strip
71
639
1.20
0.50
4.5
3.5
estimate
0.0
0.0
0.00
23
91
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
120
1.37
0.48
2.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
37
432
0.81
0.47
3.5
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
17
215
0.77
0.42
1.5
1.3
iu/ml
14.3
33.3
—
7
76
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
33
1.53
0.41
1.2
1.3
—
1.9
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
35
1.44
0.39
1.2
1.3
—
1.9
—
0
5
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
36
1.40
0.38
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
77
0.64
0.36
2.2
3.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
41
1.48
0.36
3.7
1.1
g/l
11.4
10.5
—
6
34
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
219
1.22
0.36
2.3
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.41
0.35
3.7
1.1
g/l
3.1
3.9
—
6
33
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.41
0.35
3.7
1.1
g/l
2.4
3.1
—
6
34
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.41
0.35
3.7
1.1
g/l
6.2
7.9
—
6
33
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.41
0.35
3.7
1.1
—
—
—
0
0
(3013512) EKG study
32
367
0.84
0.34
3.0
3.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
46
1.32
0.33
1.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
74
1.37
0.33
2.0
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
47
1.29
0.32
2.2
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
34
298
1.18
0.32
3.9
2.3
umol/l
349.9
10038.4
2.03
26
253
(3003327) Ova and parasites identified in Stool by Light microscopy
7
54
1.31
0.31
1.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
93
883
1.13
0.28
4.7
4.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
32
284
1.16
0.26
4.8
3.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33
368
0.87
0.25
3.2
2.8
ng/l
5895.6
1258.5
0.44
28
307
(3019060) Gas panel - Arterial blood
9
75
1.21
0.25
4.6
10.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
83
0.71
0.24
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
37
335
1.14
0.23
1.6
1.7
mmol/l
1.4
1.3
0.30
27
283
(3000492) Spirometry study
7
93
0.74
0.23
1.0
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
115
1187
0.89
0.23
24.8
12.8
%
38.0
39.9
1.15
81
857
(3049717) Cytology report of Urine Cyto stain
5
42
1.20
0.21
2.0
1.7
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
6.6
—
0
7
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
3.7
—
0
8
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
48
1.26
0.20
1.3
1.3
—
1.6
—
0
6
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
6
48
1.26
0.20
7.3
3.3
mmol/l
25.8
24.9
—
6
48
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
50
1.21
0.20
1.3
1.1
—
—
—
0
0
(3015736) pH of Urine
53
496
1.10
0.19
4.0
3.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
42
389
1.11
0.18
3.9
3.2
mg/l
115.5
212.3
0.23
29
255
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
46
492
0.91
0.18
4.8
3.8
ng/l
33.4
108.9
0.53
37
338
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
194
0.86
0.18
1.1
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
141
0.84
0.17
1.8
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
150
0.85
0.15
8.9
6.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
9
81
1.12
0.15
5.4
2.6
kpa
5.4
5.1
—
9
73
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
119
1215
0.92
0.13
8.1
4.6
mu/l
1.6
1.8
1.08
110
1102
(3007164) IgA [Mass/volume] in Serum or Plasma
28
259
1.10
0.12
1.3
1.3
g/l
2.7
2.4
0.20
18
144
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
126
0.86
0.11
1.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
157
0.88
0.11
1.6
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
105
1.15
0.11
3.8
3.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
86
1.17
0.11
4.8
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
359
1.08
0.11
4.0
3.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.2
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
48
1.04
0.09
1.2
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
55
1.09
0.09
7.7
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
85
1.06
0.07
1.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
84
854
0.97
0.05
3.4
3.0
u/l
73.9
41.6
2.02
77
793
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
51
497
1.04
0.04
5.2
3.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
43
419
1.04
0.03
3.3
3.1
mmol/l
7.5
7.6
0.01
35
350
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
120
1210
0.97
0.03
25.3
10.2
ml/min/173m2
79.2
80.6
0.22
106
937
(3020682) Albumin/Creatinine [Ratio] in Urine
41
420
0.97
0.03
4.7
4.0
mg/mmol
20.3
7.4
0.49
26
279
(36660697) Celiac disease serology panel - Serum
10
108
0.92
0.03
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
31
301
1.04
0.02
1.1
1.4
u/ml
0.9
1.2
—
7
76
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
127
1279
0.97
0.02
22.8
11.8
mg/l
25.7
22.6
0.51
114
976
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
53
539
0.98
0.02
2.0
1.9
pmol/l
92.3
92.9
0.04
33
270
(3000494) Fungus identified in Specimen by Culture
14
147
0.95
0.01
2.4
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
134
0.97
0.00
1.2
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
20
196
1.02
0.00
3.8
2.6
ug/l
0.7
0.8
0.13
14
137
(3019225) pH of Specimen
10
103
0.97
0.00
11.7
2.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
285
1.02
0.00
8.4
3.7
%
25.0
24.7
0.04
12
140
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
4.0
—
0
5
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.3
—
0
5
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
76
0.92
0.00
1.3
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
6.9
—
0
6
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
133.8
—
0
8
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.0
—
4.7
—
0
6
(4211845)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
31.6
—
0
7
(3001019) Free T4 and TSH panel - Serum or Plasma
5
56
0.89
0.00
1.6
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
3.2
—
0
5
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
116.7
—
0
6
(4010399)
7
79
0.88
0.00
1.3
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
49
1.02
0.00
1.8
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1603.0
—
0
6
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
84
0.95
0.00
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
61
0.98
0.00
2.0
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_ENDOCRINE_NAS_EXALLC – Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).